September 2024 – Page 82

Hepatocellular Carcinoma Clinical Trials, Pipeline Insights, Treatment Drugs, and Companies 2024

DelveInsight’s, “Hepatocellular Carcinoma Pipeline Insight 2024” report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in Hepatocellular Carcinoma Research. Learn more about our innovative pipeline today! @ Hepatocellular Carcinoma Pipeline Outlook

Key Takeaways from the Hepatocellular Carcinoma Pipeline Report

In September 2024:- Translational Research in Oncology- A Phase III, Multicenter, Randomized, Open-label Trial to Evaluate the Safety and Efficacy of Systemic Therapy With Regorafenib and Pembrolizumab Versus Locoregional Therapy With Transarterial Chemoembolization or Transarterial Radioembolization, for the First-line Treatment of Intermediate-stage Hepatocellular Carcinoma With Beyond Up-to-7 Criteria
In September 2024:- Hoffmann-La Roche- This is a Phase Ib/II, open-label, multicenter, randomized platform study to evaluate neoadjuvant immunotherapy combinations in participants with resectable HCC. The study is designed with the flexibility to open new treatment arms as new agents become available, close existing treatment arms that demonstrate minimal clinical activity or unacceptable toxicity, or modify the participant population.
In September 2024:- Akeso- The goal of phase Ib trial is to evaluate the safety and tolerability of AK112 in combination therapies for the purpose of observing the incidence of dose limit toxicity (DLT) as well as the confirmation of maximum tolerable dose (MTD) in the treatment of advanced hepatocellular carcinoma (HCC), so as to determine the recommended phase 2 dose (RP2D) in the second part of the trial.
DelveInsight’s Hepatocellular Carcinoma pipeline report depicts a robust space with 90+ active players working to develop 95+ pipeline therapies for Hepatocellular Carcinoma treatment.
The leading Hepatocellular Carcinoma Companies such as Can-Fite BioPharma, Sinocelltech, AVEO Oncology, Oxford BioTherapeutics, Beijing SyngenTech, Surface Oncology, Novartis Oncology, Array BioPharma, Taizhou Hanzhong Pharmaceuticals, Akeso Biopharma, Shanghai Henlius Biotech, Chugai Pharmaceutical, CStone Pharmaceuticals, Shenogen Pharma, GlaxoSmithKline, Tarus Therapeutics, Tvardi Therapeutics, Virogin Biotech, Yiviva, Chia Tai Tianqing Pharmaceutical Group, Antengene Corporation, Iterion Therapeutics, Sumitomo Pharma, SillaJen Biotherapeutics, SCG Cell Therapy, Guangdong ProCapZoom Biosciences, Eutilex, Polaris Pharmaceuticals, OriCell Therapeutics, and others
Promising Hepatocellular Carcinoma Therapies such as Pembrolizumab, Tislelizumab, HLX53 (1000mg), Atezolizumab, Bevacizumab, Tiragolumab, Nivolumab and others

Stay informed about the cutting-edge advancements in Hepatocellular Carcinoma Treatments. Download for updates and be a part of the revolution in cancer care @ Hepatocellular Carcinoma Clinical Trials Assessment

Hepatocellular Carcinoma Emerging Drugs

Namodenoson: Can-Fite BioPharma

Namodenoson is an oral small molecule drug generically known as Cl-IB-MECA (2-chloro-N6-(3-iodobenzyl)-adenosine-5′- N-methyl-uronamide), a highly specific and selective agonist at the A3 adenosine receptor (A3AR). The drug had been out-licensed to Chong Kun Dang (CKD) Pharmaceutical in Korea and to CMS in China.for the treatment of Liver Cancer and NASH. A Phase I/II study in hepatocellular carcinoma (HCC) successfully met its primary and secondary endpoints demonstrating initial indications for efficacy of Namodenoson. A global Phase II study treating patients with Namodenoson as a second-line therapy has recently been concluded.

SRF388: Surface Oncology

SRF388 is a fully human anti-IL-27 antibody designed to inhibit the activity of this immunosuppressive cytokine. IL-27 is an immunosuppressive cytokine involved in resolving T cell mediated inflammation. Recent data points to IL-27 as a master regulator of the expression of co-inhibitory receptors expressed on CD4+ and CD8+ T cells. Elevated levels of IL-27 transcripts and mRNA gene signatures are found in cancer and are associated with poor prognoses. Surface Oncology has identified particular tumor types where IL-27 appears to play an important role in the immunosuppressive tumor microenvironment and may contribute to resistance to treatment with checkpoint inhibitors.

Porustobart: Harbour BioMed

Porustobart (HBM4003) is a fully human anti-CTLA-4 monoclonal heavy chain only antibody (HCAb) generated from mice. By enhancing antibody-dependent cell cytotoxicity (ADCC) killing activity, porustobart has demonstrated significantly improved depletion specific to high CTLA-4 Treg cells in tumor tissues. The potent anti-tumor efficacy and differentiated pharmacokinetics with durable pharmacodynamic effect presents a favorable product profile. This novel and differentiated mechanism of action has the potential to improve efficacy while significantly reducing the toxicity of the drug in monotherapy and combo-therapy.

Fisogatinib: CStone Pharmaceuticals

Fisogatinib is an orally available, potent, irreversible inhibitor of FGFR4. Fisogatinib was specifically designed to inhibit FGFR4 with exquisite selectivity, thereby sparing the paralogs FGFR1, FGFR2 and FGFR3 and preventing potential adverse effects. Preclinical data has validated FGFR4 as an oncogenic driver for a subset of patients with advanced HCC. The US Food and Drug Administration has granted orphan drug designation to fisogatinib for the treatment of HCC. Fisogatinib is being investigated in the Phase I/II stage of its development for the treatment of patients with FGFR4-activated HCC.

STP705: Sirnaomics

STP705 is composed of two siRNA oligonucleotides targeting TGF-β1 and COX-2 mRNA respectively and formulated in nanoparticles with a proprietary Histidine-Lysine Co-Polymer (HKP) peptide. Each individual siRNA has demonstrated the ability to inhibit the expression of their target mRNA and combining the two siRNAs produces a synergistic effect that diminishes pro-fibrogenic, pro-inflammatory, and pro-tumorigenic factors. Sirnaomics has completed several pre-clinical studies that demonstrate that inhibition of TGF-β1 and COX-2 and is expected to result in the inhibition of tumor growth and provide an alternative approach for the treatment of various liver cancers. Molecular analyses of the effects of administering the combination demonstrated that the inhibition of these targets had effects on downstream gene products associated with numerous oncology targets.

Learn more about Hepatocellular Carcinoma Drugs opportunities in our groundbreaking Hepatic Tumor Research and development projects @ Hepatocellular Carcinoma Unmet Needs

Hepatocellular Carcinoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

Oral
Intravenous
Subcutaneous
Parenteral
Topical

Hepatocellular Carcinoma Products have been categorized under various Molecule types such as

Recombinant fusion proteins
Small molecule
Monoclonal antibody
Peptide
Polymer
Gene therapy

Discover the latest advancements in Hepatocellular Carcinoma Treatment by visiting our website. Stay informed about how we’re transforming the future of Oncology @ Hepatocellular Carcinoma Market Drivers and Barriers, and Future Perspectives

Scope of the Hepatocellular Carcinoma Pipeline Report

Coverage- Global
Hepatocellular Carcinoma Companies- Can-Fite BioPharma, Sinocelltech, AVEO Oncology, Oxford BioTherapeutics, Beijing SyngenTech, Surface Oncology, Novartis Oncology, Array BioPharma, Taizhou Hanzhong Pharmaceuticals, Akeso Biopharma, Shanghai Henlius Biotech, Chugai Pharmaceutical, CStone Pharmaceuticals, Shenogen Pharma, GlaxoSmithKline, Tarus Therapeutics, Tvardi Therapeutics, Virogin Biotech, Yiviva, Chia Tai Tianqing Pharmaceutical Group, Antengene Corporation, Iterion Therapeutics, Sumitomo Pharma, SillaJen Biotherapeutics, SCG Cell Therapy, Guangdong ProCapZoom Biosciences, Eutilex, Polaris Pharmaceuticals, OriCell Therapeutics, and others
Hepatocellular Carcinoma Therapies- Pembrolizumab, Tislelizumab, HLX53 (1000mg), Atezolizumab, Bevacizumab, Tiragolumab, Nivolumab and others
Hepatocellular Carcinoma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
Hepatocellular Carcinoma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Hepatocellular Carcinoma Pipeline on our website @ Hepatocellular Carcinoma Drugs and Companies

Table of Content

Introduction
Executive Summary
Hepatocellular Carcinoma: Overview
Pipeline Therapeutics
Therapeutic Assessment
Hepatocellular Carcinoma– DelveInsight’s Analytical Perspective
Late Stage Products (Phase III)
Namodenoson: Can-Fite BioPharma
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
SRF388: Surface Oncology
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
STP705: Sirnaomics
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Drug name: Company name
Drug profiles in the detailed report…..
Inactive Products
Hepatocellular Carcinoma Key Companies
Hepatocellular Carcinoma Key Products
Hepatocellular Carcinoma- Unmet Needs
Hepatocellular Carcinoma- Market Drivers and Barriers
Hepatocellular Carcinoma- Future Perspectives and Conclusion
Hepatocellular Carcinoma Analyst Views
Hepatocellular Carcinoma Key Companies
Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hepatocellular Carcinoma Clinical Trials, Pipeline Insights, Treatment Drugs, and Companies 2024

Ogden Deck Depot Named Best Lumber Yard in Ogden, Utah

Ogden Deck Depot Logo

Lumber Yard at Ogden Deck Depot

Ogden, Utah – September 20, 2024 – Ogden Deck Depot is proud to announce its recent recognition as the best lumber yard in Ogden, Utah. This award highlights Ogden Deck Depot’s dedication to providing top-quality lumber yard services and its commitment to serving the local community with the finest deck lumber and building materials. Specializing in high-quality lumber and exceptional customer service, Ogden Deck Depot has become the go-to destination for homeowners, contractors, and builders looking for reliable lumber solutions.

Ogden Deck Depot has earned its reputation by offering a wide range of lumber yard services that cater to the needs of DIY enthusiasts and professional builders alike. Whether you’re working on a custom deck, a home renovation, or a larger construction project, Ogden Deck Depot ensures you have access to the best materials available.

“We are honored to be recognized as the top lumber yard in Ogden,” said the Owner of Ogden Deck Depot. “Our focus has always been on providing our customers with the highest quality lumber, deck lumber, and materials, along with excellent service. This recognition reflects our team’s hard work and dedication to helping our community build and improve their outdoor spaces.”

Comprehensive Lumber Yard Services

Ogden Deck Depot is known for its extensive inventory and range of services, designed to meet the diverse needs of customers. From selecting the right type of lumber for your project to providing guidance on deck construction, the team at Ogden Deck Depot is committed to helping customers achieve their goals.

Their key offerings include:

Deck Lumber: A wide selection of high-quality deck lumber, including pressure-treated wood, cedar, and composite options, ensures durability and style for every deck project.
Framing and Structural Lumber: Premium lumber options for framing and structural needs, ideal for everything from residential construction to commercial projects.
Custom Lumber Orders: Personalized assistance for custom lumber orders to ensure you have the exact materials you need for any project, regardless of size or complexity.
Expert Guidance and Support: The team at Ogden Deck Depot offers knowledgeable advice to help you choose the best materials and lumber for your specific project. Their hands-on support ensures customers can confidently tackle any building task.

“Whether you’re looking for deck lumber or materials for a larger construction project, our team is here to guide you every step of the way,” said the Operations Manager at Ogden Deck Depot. “We understand how important it is to have the right materials, and we are committed to helping our customers succeed in their projects with the best lumber available.”

The Best Lumber for Deck Construction

Ogden Deck Depot specializes in providing deck lumber that meets the highest standards of quality and durability. Their extensive selection includes pressure-treated lumber, composite decking materials, and specialty wood products, ensuring that customers can find the perfect materials for their decks. With a focus on sustainable and long-lasting products, Ogden Deck Depot helps homeowners and contractors create outdoor spaces that are built to last.

Looking to the Future

As Ogden Deck Depot continues to serve as the premier lumber yard in Ogden, the company is dedicated to expanding its offerings and enhancing its customer experience. With plans to introduce new lumber products and services in the coming months, Ogden Deck Depot remains committed to being a trusted resource for all building and deck construction needs in Northern Utah.

To celebrate this recognition, Ogden Deck Depot will be hosting an open house, where customers can explore the lumber yard, meet the team, and take advantage of special promotions on deck lumber and other building materials. The event will feature product demonstrations, expert consultations, and exclusive discounts for attendees.

About Ogden Deck Depot

Ogden Deck Depot has been a trusted provider of lumber and building materials in Ogden, Utah, for years. With a focus on quality, customer satisfaction, and expert support, Ogden Deck Depot has established itself as the leading lumber yard in the region. Offering a comprehensive selection of deck lumber, framing materials, and custom orders, Ogden Deck Depot is the preferred choice for builders and homeowners looking for the best materials for their projects.

For more information, visit https://www.ogdendeckdepot.com/ or contact Ogden Deck Depot at (435) 222-5819 or ogdendecks@gmail.com.

Media Contact
Company Name: Ogden Deck Depot
Contact Person: AJ Van Dugteren
Email: Send Email
Phone: (435) 222-5819
Address:190 W 33rd Street #160
City: Ogden
State: Utah 84401
Country: United States
Website: www.ogdendeckdepot.com/

The Disc Chiropractic Launches Advanced Shockwave Therapy for Non-Invasive Pain Relief

Lower Back Pain

The Disc Chiropractic introduces Shockwave Therapy, a non-invasive solution for chronic pain relief, using acoustic waves to accelerate healing. Effective for conditions like plantar fasciitis and shoulder tendinitis, the therapy offers quick recovery with minimal downtime and serves as a cost-effective alternative to surgery and medication. Combining this with X-ray diagnostics and spinal decompression, The Disc Chiropractic provides advanced, comprehensive care for patients seeking pain relief

Surprise, AZ – The Disc Chiropractic is excited to announce the launch of its newest service: Shockwave Therapy, an innovative, non-invasive treatment designed to provide effective pain relief for patients suffering from chronic musculoskeletal conditions. This cutting-edge technology delivers acoustic waves to target pain points and stimulate the body’s natural healing processes, offering a powerful alternative to surgery and medication.

Key Benefits of Shockwave Therapy:

Non-Invasive Pain Relief: Shockwave Therapy effectively addresses pain without the need for invasive surgery or long-term medication use, making it a safer alternative for patients.
Quick Recovery Times: Treatment sessions typically last around 15 minutes, with minimal downtime, allowing patients to return to their daily routines faster.
Effective for Chronic Conditions: This therapy has shown significant success in treating chronic conditions such as plantar fasciitis, shoulder tendinitis, and tennis elbow, improving both pain levels and mobility.
Cost-Effective: By reducing the need for expensive surgeries and medications, Shockwave Therapy offers a more affordable solution for long-term pain management.

The Disc Chiropractic is proud to introduce this advanced treatment, aligning with the industry’s shift toward more holistic and technologically advanced care options. “Our practice is dedicated to staying at the forefront of chiropractic care, and Shockwave Therapy exemplifies our commitment to offering modern, effective treatments,” said Dr. Al Simeone.

Setting Us Apart The Disc Chiropractic combines advanced technology with a personalized approach to patient care. Offering a unique combination of X-ray diagnostics, spinal decompression, and Shockwave Therapy, the practice provides comprehensive solutions for diagnosing and treating musculoskeletal issues, ensuring tailored and highly effective treatment plans.

For more information about Shockwave Therapy and other services offered by The Disc Chiropractic, visit https://thediscchiropractic.com/ or contact 7205734910.

Media Contact
Company Name: The Disc Chiropractic
Contact Person: Dr. Al Simeone
Email: Send Email
Phone: (720) 573-4910
Address:6990 W 38th Ave #205
City: Wheat Ridge
State: CO
Country: United States
Website: https://thediscchiropractic.com/

Mobile Apps and Web Analytics Market Size, Share, Future Trends, Growth Factors, Industry Analysis, Advance Technology And Forecast – 2027

“Microsoft (US), Google (US), Oracle (US), SAP (US), AWS, IBM (US), Teradata (US), Adobe (US), SAS Institute (US), Micro Focus (US), comScore (US), Salesforce (US), Splunk (US), Microstrategy (US), AT Internet (US), Webtrends (US), Tibco Software (US), Mixpanel (US), Upland Localytics (US), Amplitude Analytics (France), Qlik (US), Flurry (US), Cooldata (US), Countly (UK).”

Mobile Apps and Web Analytics Market by Component (Solutions & Services), Solution (Data Analytics, Data Discovery), Application (Content Marketing, Marketing Automation), Deployment Mode, Organization Size, Vertical and Region – Global Forecast to 2027.

The Mobile Apps and Web Analytics market is expected to grow from USD 9.4 billion in 2022 to USD 20.2 billion by 2027, with a compound annual growth rate (CAGR) of 16.4% over the forecast period. This practical domain integrates both traditional and modern disciplines to develop, model, align, execute, analyze, and refine decision-making models and operations. These analytics solutions leverage behavioral and operational insights to collect data on app performance and user behavior, providing actionable insights to enhance user experience, boost engagement, and improve overall reliability.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139197732

Cloud segment to account for higher CAGR during the forecast period

The Mobile Apps and Web Analytics market is bifurcated on the basis of cloud and on-premises. The market size of the cloud deployment mode is estimated to be larger and projected to have a higher CAGR during the forecast period. The new means to access technology and the information a company needs to react rapidly to shifting markets and address business issues is made possible by cloud computing. It introduces a new technique for creating platforms, infrastructure, and services. Today’s business professional finds it harder than ever to find data-driven insights. Business customers typically receive static spreadsheets and presentations from analytical experts that are challenging to examine and manipulate.

SMEs segment to account for higher CAGR during the forecast period

The Mobile Apps and Web Analytics market is bifurcated on the basis of large enterprises and SMEs. The CAGR of the SMEs is estimated to be highest during the forecast period. SMEs make up a vast majority of enterprises globally and play a significant role in most economies. Analytics-based data helps improve overall business intelligence and assists in making wise business decisions. Web analytics is crucial for businesses to identify and comprehend the target market. This information can be very helpful, especially if the business is global or is considering entering a new market. This, in turn, would enable SMEs to adopt mobile apps and web analytics platforms and services.

APAC to hold higher CAGR during the forecast period

Over the next five years, the Asia Pacific region is expected to witness the fastest growth in the Mobile Apps and Web Analytics market. SMEs and large enterprises in Asia Pacific have become more aware of government regulations and compliances and started adopting AI-based solutions proactively. The adoption of AI technology by different verticals, such as the BFSI, travel and hospitality, and retail, is expected to contribute to the high growth of the mobile apps & web analytics market. The growing eCommerce, online streaming, and increasing internet penetration have resulted in the growth of marketing industries. Marketers now look for more sophisticated marketing solutions for a large, ever-growing consumer base. This, in turn, has resulted in the adoption of AI-enabled solutions for marketing.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=139197732

Unique Features in the Mobile Apps and Web Analytics Market

This rapid growth highlights the increasing importance of data-driven insights for businesses aiming to improve app functionality and user experience. A unique feature of this market is its ability to blend both traditional and cutting-edge disciplines. Mobile Apps and Web Analytics solutions merge well-established data analysis techniques with innovative technologies to build, model, and refine decision-making frameworks. This convergence allows for more comprehensive and actionable insights into both app performance and user behavior.

These solutions stand out due to their integration of behavioral and operational analytics, which track not only the technical performance of apps but also user interactions. By understanding how users engage with apps, businesses can optimize the user experience and adapt their offerings to meet evolving needs, leading to higher engagement and retention rates.

Another distinctive aspect is the focus on using collected data to continually enhance the user experience. The insights derived from analytics allow for ongoing adjustments to app design and functionality, ensuring apps remain engaging, responsive, and reliable, thus fostering long-term user loyalty and satisfaction.

The ability to make real-time adjustments based on analytics is a key feature of this market. Mobile Apps and Web Analytics solutions offer immediate insights into app performance and user activity, enabling businesses to quickly address issues, optimize operations, and make informed decisions to enhance the overall effectiveness of their mobile and web platforms.

Major Highlights of the Mobile Apps and Web Analytics Market

A major highlight of the market is the integration of both traditional and modern analytical disciplines. These solutions bring together time-tested data analysis methods and cutting-edge technologies, enabling businesses to build, align, and refine decision models that drive performance and strategic improvements.

The market is distinguished by its focus on combining behavioral and operational analytics. These tools provide deep insights into both app performance and user interactions, allowing businesses to monitor how their apps function and how users engage with them. This comprehensive data enables the continuous optimization of user experience and app efficiency.

A standout feature of Mobile Apps and Web Analytics is its ability to drive continuous improvements in user experience. The insights generated allow businesses to fine-tune app functionality in real time, ensuring that user needs are met, which in turn increases engagement, satisfaction, and loyalty.

The real-time decision-making capability of these analytics solutions is a key highlight. By providing instant feedback on app performance and user behavior, businesses can swiftly address issues, make data-driven adjustments, and optimize their operations to ensure that their apps remain reliable and engaging for users.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=139197732

Top Companies in the Mobile Apps and Web Analytics Market

Major vendors in the global Mobile Apps and Web Analytics market are Microsoft (US), Google (US), Oracle (US), SAP (US), AWS, IBM (US), Teradata (US), Adobe (US), SAS Institute (US), Micro Focus (US), comScore (US), Salesforce (US), Splunk (US), Microstrategy (US), AT Internet (US), Webtrends (US), Tibco Software (US), Mixpanel (US), Upland Localytics (US), Amplitude Analytics (France), Qlik (US), Flurry (US), Cooldata (US), Countly (UK), Mobilebridge (Netherlands), Appsflyer (US), Uxcam (US), Incubasys (UAE), Datamatics Technologies (UAE), Alpha Byte (UAE), Celadon (UAE), Singular (Israel), Matomo (New Zealand), Plausible (Estonia), and Fathom (US).

IBM:

IBM is a multinational technology and consulting corporation that offers infrastructure, hosting, and consulting services. The company operates through five major business segments: cognitive solutions, global business services, technology services and cloud platforms, systems, and global financing. IBM offers mobile and web analytics solutions to set up and manage mobile and web so apps can access live and historical data. . It maintains strong partner relationships with leading IT providers such as AWS, Adobe, Cisco, KPMG, Kyndryl, Microsoft, Oracle, Salesforce, Samsung, SAP, ServiceNow, and Workday. The company has a presence in North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. In January 2022, IBM announced its acquisition of Envizi, a leading data and analytics software provider for environmental performance management.

ComScore:

ComScore is a leading company offering media and marketing measurement and analytics solutions. The company was founded in 1999 and is headquartered in Virginia, US. It offers a wide variety of audience and advertising analytics software solutions to its clients to understand audiences across platforms, such as mobile, desktops, and televisions. The company has a presence in more than 20 companies across the globe and caters to more than 2,500 clients in media, advertising, and marketing verticals, globally. In the mobile apps and web analytics market, comScore allows media buyers and sellers to quantify their multiscreen behavior and make business decisions.

Webtrends:

Webtrends is a leading provider of data analytics and personalization solutions. The company delivers actionable insights and helps boost customer engagement. It is an eminent provider of enterprise management and reporting solutions. Webtrends’ products are specifically designed to enable organizations to administer various internet-based systems throughout organizations, regardless of the geographic locations of servers supporting the systems. The company has a geographic presence in the US, EMEA, France, and Germany. It delivers extensive software-based analytics solutions in the field of web analytics, social media analytics, and mobile analytics under its product division called Webtrends Streams. These solutions assist businesses from numerous verticals, such as media, retail and consumer goods, healthcare and life sciences, travel and leisure, and telecommunication, in collecting, organizing, analyzing, and transforming raw customer information into useful data.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/mobile-apps-and-web-analytics-market-139197732.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Mobile Apps and Web Analytics Market Size, Share, Future Trends, Growth Factors, Industry Analysis, Advance Technology And Forecast – 2027

HER2-Negative Breast Cancer Pipeline Insights, Treatment Drugs, Emerging Therapies and Companies 2024

DelveInsight’s, “HER2-Negative Breast Cancer Pipeline Insight 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2-Negative Breast Cancer pipeline landscape. It covers the HER2-Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in HER2-Negative Breast Cancer Research. Learn more about our innovative pipeline today! @ HER2-Negative Breast Cancer Pipeline Outlook

Key Takeaways from the HER2-Negative Breast Cancer Pipeline Report

In September 2024:- Borstkanker Onderzoek Groep– This is a multicenter phase 2 study evaluating the efficacy and safety of trifluridine/tipiracil in women with metastatic or locally advanced breast cancer not amenable to curative treatment by surgery or radiotherapy.
In September 2024:- RayzeBio Inc.- Phase 1b/2 Open-label Trial of 225Ac-DOTATATE (RYZ101) Alone and in Combination with Pembrolizumab in Subjects with Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-negative, Locally Advanced and Unresectable or Metastatic Breast Cancer Expressing Somatostatin Receptors (SSTRs) and Progressed After Antibody-drug Conjugates And/or Chemotherapy (TRACY-1)
In September 2024:- Hoffmann-La Roche- A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Hormone Receptor-Positive HER2-Negative Breast Cancer (MORPHEUS-HR+ Breast Cancer).
DelveInsight’s HER2-Negative Breast Cancer pipeline report depicts a robust space with 70+ active players working to develop 75+ pipeline therapies for HER2-Negative Breast Cancer treatment.
The leading HER2-Negative Breast Cancer Companies such as Genentech, CytomX Therapeutics, H3 Biomedicine, Regor Therapeutics, Immutep Limited, Merck & Co, Klus Pharma, Olema Pharmaceuticals, BeiGene, AstraZeneca, Janssen/Merck/GSK, Ono Pharmaceutical, Laekna Therapeutics, NanoMab, InSilico Medicine, TYK Medicine, Shanghai Pharmaceutical Group, Verastem Oncology, Allarity Therapeutics, Shenzhen Yangli Pharmaceutical Technology, Phoenix Molecular Designs, and others.
Promising HER2 Negative Breast Cancer Therapies such as Doxorubicin, Cyclophosphamide, Utidelone Combined with Bevacizumab, Capecitabine, Carboplatin, Cisplatin, and others.

Stay informed about the cutting-edge advancements in HER2-Negative Breast Cancer Treatments. Download for updates and be a part of the revolution in cancer care @ HER2-Negative Breast Cancer Clinical Trials Assessment

HER2-Negative Breast Cancer Emerging Drugs

Giredestrant : Genentech

Giredestrant is a novel investigative small molecule that works as selective estrogen receptor degrader (SERD) by targeting the estrogen receptor (ER). The drug candidate is a new molecular entity (NME) which is administered through oral route. Preclinical studies suggest that Giredestrant is orally bioavailable and competitively inhibits the binding of estrogen to the ER. In preclinical models, Giredestrant has been shown to restrain the normally dynamic behavior of both wild-type and mutant ER, immobilizing the ER and attenuating the expression of its target genes. Currently, the drug is in Phase III stage of its development for the treatment of HER2 negative breast cancer.

Inavolisib : Genentech

Inavolisib is an investigational small molecule designed to selectively inhibit mutant PI3Kα. In preclinical models, the molecule showed potent selective inhibition of PI3Kα and has increased potency to mutant PI3K cells over wild type. It is less sensitive for the other three PI3K isoforms. Inavolisib binds to the ATP-binding site of PI3Kα, thereby blocking phosphorylation of PIP2 to PIP3 and preventing downstream signaling as shown in preclinical models. Moreover, inavolisib specifically degrades the mutant form of PI3Kα, resulting in reduction of pathway activity. Currently the drug is in Phase III stage of its development for the treatment of HER2 negative breast cancer.

CX-2009 : CytomX Therapeutics

CX-2009 (Praluzatamab ravtansine) is a conditionally activated antibody-drug conjugate (ADC) comprised of a CD166-directed humanized monoclonal antibody conjugated to the maytansinoid DM4, a tubulin inhibitor. Praluzatamab ravtansine utilizes CytomX Probody® platform technology, which incorporates a masking peptide to cover and block the cellular binding region of the antibody. Tethered to the antibody via a protease-cleavable linker, currently, the drug is in Phase II stage of its development for the treatment of HER2 negative breast cancer.

H3B 6545 : H3 Biomedicine

H3B-6545 is an oral, selective estrogen receptor covalent antagonist (SERCA) for the research of metastatic ER-positive, HER2-negative breast cancer. H3B- 6545, a first-in-class small molecule selective estrogen receptor covalent antagonist (SERCA) demonstrates activity in tumor models that harbor wild-type or mutant ERα.4 H3B-6545 activity against ERα mutants resistant to standard therapy provides an opportunity to target a currently unmet medical need both as a single agent and in combination with other breast cancer therapies. Currently, the drug is in Phase II stage of its development for the treatment of HER2 negative breast cancer.

RGT-419B : Regor Therapeutics

RGT-419B is a new generation of CDK inhibitor with an optimized kinase activity spectrum. Results from non-clinical studies showed that RGT-419B demonstrated full suppression of ER+ breast cancer cell proliferation with acquired resistance to CDK4/6 inhibitors. Additionally, RGT-419B’s tumor cell suppression was further augmented when combined with a selective estrogen receptor down-regulator or a PI3K signaling pathway inhibitor. Currently, the drug is in Phase I stage of its development for the treatment of HER2 negative breast cancer.

Learn more about HER2-Negative Breast Cancer Drugs opportunities in our groundbreaking Hepatic Tumor Research and development projects @ HER2-Negative Breast Cancer Unmet Needs

HER2-Negative Breast Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

Oral
Parenteral
Intravitreal
Subretinal
Topical

HER2-Negative Breast Cancer Products have been categorized under various Molecule types such as

Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy

Discover the latest advancements in HER2-Negative Breast Cancer Treatment by visiting our website. Stay informed about how we’re transforming the future of Oncology @ HER2-Negative Breast Cancer Market Drivers and Barriers, and Future Perspectives

Scope of the HER2-Negative Breast Cancer Pipeline Report

Coverage- Global
HER2-Negative Breast Cancer Companies- Genentech, CytomX Therapeutics, H3 Biomedicine, Regor Therapeutics, Immutep Limited, Merck & Co, Klus Pharma, Olema Pharmaceuticals, BeiGene, AstraZeneca, Janssen/Merck/GSK, Ono Pharmaceutical, Laekna Therapeutics, NanoMab, InSilico Medicine, TYK Medicine, Shanghai Pharmaceutical Group, Verastem Oncology, Allarity Therapeutics, Shenzhen Yangli Pharmaceutical Technology, Phoenix Molecular Designs, and others.
HER2 Negative Breast Cancer Therapies- Doxorubicin, Cyclophosphamide, Utidelone Combined with Bevacizumab, Capecitabine, Carboplatin, Cisplatin, and others.
HER2-Negative Breast Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
HER2-Negative Breast Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of H HER2-Negative Breast Cancer Pipeline on our website @ HER2-Negative Breast Cancer Drugs and Companies

Table of Content

Introduction
Executive Summary
HER2 Negative Breast Cancer: Overview
Pipeline Therapeutics
Therapeutic Assessment
HER2 Negative Breast Cancer– DelveInsight’s Analytical Perspective
Late Stage Products (Phase III)
Giredestrant : Genentech
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
CX-2009 : CytomX Therapeutics
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
RGT-419B : Regor Therapeutics
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Drug Name: Company Name
Drug profiles in the detailed report…..
Inactive Products
HER2 Negative Breast Cancer Key Companies
HER2 Negative Breast Cancer Key Products
HER2 Negative Breast Cancer- Unmet Needs
HER2 Negative Breast Cancer- Market Drivers and Barriers
HER2 Negative Breast Cancer- Future Perspectives and Conclusion
HER2 Negative Breast Cancer Analyst Views
HER2 Negative Breast Cancer Key Companies
Appendix

About Us

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: HER2-Negative Breast Cancer Pipeline Insights, Treatment Drugs, Emerging Therapies and Companies 2024

EV Charging Equipment Market to Hit $46.13 Billion by 2029, 2X Growth in the Next 6 Years – Exclusive Research Report by Arizton

“EV Charging Equipment Market Research Report by Arizton”

According to Arizton’s latest research report, the EV charging equipment market is growing at a CAGR of 14.32% during 2023-2029.

Looking for More Information? Click: https://www.arizton.com/market-reports/ev-charging-equipment-market

Report Scope:   

Market Size (2029): $46.13 Billion       

Market Size (2023): $20.67 Billion       

CAGR (2023-2029): 14.32%  

Historic Year:  2020-2022           

Base Year: 2023           

Forecast Year: 2024-2029           

Market Segmentation: Product, End-Users, Components, and Geography

Geographical Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa   

Book the Free Sample Now: https://www.arizton.com/market-reports/ev-charging-equipment-market

As the world intensifies its efforts to combat climate change, the electric vehicle (EV) charging equipment market is experiencing significant growth. Governments across the globe are implementing stringent emission regulations and setting ambitious targets to promote EV adoption.

The European Union, for example, has committed to a remarkable 37.5% reduction in CO2 emissions from new cars by 2030 compared to 2021 levels. Similarly, pioneering nations like Norway and the Netherlands are leading the charge with plans to ban the sale of new internal combustion engine vehicles by 2025 and 2030, respectively.

These proactive regulatory frameworks are compelling automotive manufacturers to accelerate their EV production. As the number of electric vehicles on the road continues to rise, the demand for robust and extensive charging infrastructure is becoming increasingly critical.

This convergence of environmental policy and automotive innovation presents a unique opportunity for growth within the EV charging equipment market, as stakeholders work together to create a sustainable future.

Key Market Development in the Global EV Charging Equipment Market

In 2024, the EVBox group partnered with SMEG to supply 300 Troniq Modular fast charging stations to EVzen, boosting its presence in France and expanding its share of the European EV charging equipment market.
In 2024, ChargePoint, Inc. and LG Electronics have partnered to innovate EV charging, combining the company management software with LG’s hardware. This partnership enhances both companies’ positions in the EV charging market, leveraging their combined expertise for advanced infrastructure projects.

Key Company Profiles

ABB
Alfen N.V.
ChargePoint, Inc.
Delta Electronics, Inc.
Eaton
EVBox Group
Kempower
StarCharge
TELD New Energy Co. Ltd
Wallbox Chargers, S.L.
Aclara Technologies
Aeidth Technologies
AMPECO LTD
Blink Charging Co.
Bolt.Earth
bp pulse
ChargeHub
Chargemaster
chargeMOD
Delphi Technologies
Driivz
Efacec
Enel X Way
Enphase Energy
EVQ Point
GARO
Green Energy Wallet
IES Synergy
IOTECHA
Landis+Gyr
Leviton Manufacturing Co., Inc
Okaya EV Pvt. Ltd.
Pod Point
QuantumEV
Schneider Electric
Shanghai Xundao New Energy Technology Co., Ltd.
Sicon Chat Union Electric Co., Ltd.
Siemens
SimplyFuel Solutions
SYNOP
Tap Electric
Tesla
Titan Power
Tridens d.o.o.
Volttic EV Charging
Xuji Group Co., Ltd.

AC Chargers Dominate Global EV Charging Equipment Market in 2023

In 2023, the AC product segment leads the global EV charging equipment market, capturing the largest share of revenue. This dominance is attributed to the cost-effectiveness, seamless grid integration, and ongoing technological advancements associated with AC chargers. Their flexibility, especially for overnight home charging using off-peak electricity rates, enhances their appeal among EV owners, further boosting market growth.

AC chargers can be easily integrated into existing electrical grids, which is crucial as these grids adapt to meet the rising demand from electric vehicles. Additionally, this integration allows businesses and municipalities to expand charging networks without incurring significant upfront costs. Continuous improvements in charging technology, including faster charging speeds and more efficient systems, are expected to further drive demand for AC chargers in the coming years.

Market Segmentation

Product

End-Users

Residential
Commercial

Components

Hardware
Software

Geographical Overview

The demand for EV charging equipment is rapidly increasing worldwide, driven by technological innovations, supportive government policies, rising environmental awareness, and greater consumer adoption of electric vehicles (EVs). In North America, growing environmental consciousness and lower operational costs are fueling consumer demand for EVs, prompting automakers to expand their offerings and increasing the need for robust charging infrastructure. Utilities and private companies are actively investing in fast-charging networks, alleviating range anxiety for EV owners.

Europe leads in EV adoption and charging infrastructure, with the European Commission targeting 3.5 million charging points by 2030 to meet stringent carbon reduction goals. Countries like Norway, Germany, and the UK are implementing significant incentives to promote EV use.

The APAC region, particularly China, Japan, South Korea, and India, is also witnessing substantial growth. China’s government initiatives and subsidies are pivotal in driving EV adoption, while Japan and South Korea set ambitious targets for infrastructure development. In India, government schemes are furthering EV acceptance and infrastructure investment.

In Latin America, countries like Brazil and Mexico are beginning to invest in EV infrastructure, although adoption remains limited by costs. Meanwhile, the Middle East and Africa are emerging markets for EV charging, with the UAE and South Africa leading investment efforts.

As the prevalence of EVs increases and charging technology evolves, the demand for EV charging equipment is expected to rise, transforming the future of transportation and energy systems globally.

Geography

APAC

China
South Korea
Japan
India
Australia
Thailand
New Zealand

Europe

Netherlands
France
Germany
The U.K.
Italy
Belgium
Spain

North America

The U.S.
Canada

Latin America

Brazil
Mexico
Colombia

Middle East & Africa

South Africa
The UAE
Egypt

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4456

Key Questions Answered in the Report:   

What is the growth rate of the global EV charging equipment market?

How big is the global EV charging equipment market?

What are the significant trends in the EV charging equipment market?

Which region dominates the global EV charging equipment market share?

Who are the key players in the global EV charging equipment market?

Check Out Some of the Top Selling Research Reports: 

Automotive Electric Seats Market – Global Outlook & Forecast 2023-2028: The global automotive electric seats market was valued at USD 62 billion in 2022 and is expected to reach USD 85.62 billion by 2028, growing at a CAGR of 5.53%. Explore! https://www.arizton.com/market-reports/automotive-electric-seats-market

Electric Vehicle Battery Recycling Market – Global Outlook & Forecast 2023-2028

The electric vehicle battery recycling market size was valued at USD 8.20 billion in 2022 and is expected to reach USD 20.06 billion by 2028, growing at a CAGR of 16.08% during the forecast period. Explore! https://www.arizton.com/market-reports/electric-vehicle-battery-recycling-market

Why Arizton?                                            

100% Customer Satisfaction                                            

24×7 availability – we are always there when you need us                                            

200+ Fortune 500 Companies trust Arizton’s report                                            

80% of our reports are exclusive and first in the industry                                            

100% more data and analysis                                            

1500+ reports published till date                          

Post-Purchase Benefit                                        

1hr of free analyst discussion                                        
10% off on customization

About Us:                                                                                 

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                               

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                                

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040/+1 302 469 0707  
Country: United States
Website: https://www.arizton.com/market-reports/ev-charging-equipment-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: EV Charging Equipment Market to Hit $46.13 Billion by 2029, 2X Growth in the Next 6 Years – Exclusive Research Report by Arizton

Health and Wellness Market Forecast to Grow at 8.8% CAGR from 2024 to 2031 | SkyQuest Technology

“Health and Wellness Market”

Global Health and Wellness Market size was valued at USD 6.64 trillion in 2023 to USD 13.03 trillion by 2031, growing at a CAGR of 8.8% during the forecast period (2024-2031).

Global Health and Wellness Market size was valued at USD 6.1 trillion in 2022 and is poised to grow from USD 6.64 trillion in 2023 to USD 13.03 trillion by 2031, growing at a CAGR of 8.8% during the forecast period (2024-2031).

The global health and wellness market is considered to grow due to the increased prevalence of long-term diseases such as hypertension, diabetes, asthma, arthritis, cancer, dementia, and other diseases. This encouraged various activities related to health, including yoga, meditation, and sport. Furthermore, the market is expected to experience growth due to some factors such as rise in health awareness among consumers, rapid urbanization, surge in disposable incomes, and increase in the adoption of wearables, including fitness bands and trackers.

This is driven by the rapidly growing wellness tourism and mineral spa industries. Specialized therapeutic water, such as iodine-bromine and Malinskaya mineral water, was used by the spa operator to treat various cardiovascular alignment problems, anomalies in circulation, asthma, and other conditions. Wellness tourism is tourism that combines yoga, meditation, and field trips to farms with numerous leisure activities for physical and emotional well-being.

Get a Free Sample Research Report:https://www.skyquestt.com/sample-request/health-and-wellness-market

Health and Wellness Market Segmental AnalysisGlobal Health and Wellness Market is segmented by Category, Functionality, Distribution Channel, Vertical and Region.

Based on Category, the market is segmented into Functional Foods & Beverages, Beauty & Personal Care Products, Personalized Medicinal Products, Others.

Based on Functionality, the market is segmented into Nutrition & Weight Management, Heart & Gut Health, Immunity, Bone Health, Skin Health, Others.

Based on Distribution Channel, the market is segmented into Online, Offline (Supermarkets & Hypermarkets, Retail Stores, Others).

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Corporate Wellness Programs Is a Response to Increasing Health ChallengesOne trend to the market growth is the increase in demand by business organizations to take care of and promote workplace health and wellness programs in their respective workplaces. This is attributed to the rapid rise of mental disorders alongside other fatal chronic conditions such as hypertension, diabetes, obesity, and many others. For instance, it was reported that the sudden COVID-19 pandemic affected the productivity of 74% of workers because of poor mental health, and it is here where health and well-being initiatives at work become highly crucial. These agencies, therefore, join hands with various gyms, mental health professionals, nutritionists, and other fitness and wellness experts across the globe to ensure training and counseling for their personnel. For instance, GYMGUYZ-a gold standard in in-home, virtual, and on-site personal training professional services-recently announced expansion into its corporate wellness offerings. This company recently offered its corporate wellness services to employees who wanted to work from home both at home and on-site at corporate sites and facilities. These developments will increase the value of the health and wellness sector over the forecast period.

Ask for Customization:https://www.skyquestt.com/speak-with-analyst/health-and-wellness-market

This report covers following players:

Johnson & Johnson
Nestle
Unilever
Procter & Gamble (P&G)
Abbott Laboratories
Bayer AG
Pfizer Inc.
Sanofi
Danone
Colgate-Palmolive
Kellogg’s
Amway
Merck & Co.
Novartis
Roche
Natura & Co
Philips Healthcare
Reckitt Benckiser
Medtronic
Kimberly-Clark

How Companies are Advancing Health and Wellness for Better ProductivityWith the rising need for health and wellness services, many businesses across the globe are striving hard to ensure that all can access them. People are realizing how important preventative care is in improving worker productivity and reducing medical expenses. For instance, the community-based wellness platform mHealth introduced the holistic wellness community for C-suite. This workplace wellness business promotes daily intake of food and nutrition, physical activities, mental health, long-term care, etc. As such, mHealth would improve the mental, emotional, and physical wellbeing of the community to provide comprehensive solutions to the CXOs and their families.

Competitive Insights into the Health and Wellness MarketThe health and wellness market is extremely competitive, with well-known companies ranging from Peloton, Fitbit, and Nike to a growing list of innovative startups, as key players. They compete on everything from mental wellness apps to exercise equipment. Two such trends that are really changing the face of the market and have brought cooperation along with competition are digital health technology and personalized health solutions. Tactics play a very important role, and these must be inclusive of technology usage, health integration in daily life, and focus on niche markets.

Move of Key Players in the Health and Wellness Market

In September 2023, The Shiseido Company launched a new line of wellness products or brands named “Shiseido Beauty Wellness”. Well-renowned Japanese Cosmetics brand Shiseido is expanding its business by trying to launch this new range of products in all of Asia. These initial R&D activities will take place in Japan with Kagome and Tsumura before the company expands into other countries.
In October 2023, Nestlé had come up with a small number of plant-based alternatives for white fish; it developed fish fingers ranging from nuggets to breaded fillets. For this reason, these alternatives are highly nutritious yet have a taste and texture very similar to white fish.
In November 2023, government bodies across the country would rename Ayushman Bharat-Health and Wellness Centers as “Ayushman Arogya Mandir.” “These centers have been successfully initiating positive measures in the healthcare industry to avoid chronic diseases,” the Ministry wrote in a letter dated November 25.

This report covers following segments:

A. Category

Functional Foods & Beverages
Beauty & Personal Care Products

B. Functionality

Nutrition & Weight Management
Heart & Gut Health

C. Distribution Channel

Online
Offline

View report summary and Table of Contents (TOC):https://www.skyquestt.com/report/health-and-wellness-market

The global rise in the acceptance of wellness and health-related programs amongst working adults as a means of being in control of sedentary lives and, subsequently, assisting in the better decision making for a happy life is contributing to the global expansion of health and wellness market. This health and wellness market’s scope is going to be further extended by several other variables such as increasing disposable income levels, expanding functional drinks consumption, and growing demand for personal care maintenance.

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/health-and-wellness-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Health and Wellness Market Forecast to Grow at 8.8% CAGR from 2024 to 2031 | SkyQuest Technology

Wearable Art Startup, All Seeing Studios will be your Next Major Find at Magic NYC 2024

Founder Sara Rubenstein’s Ethereal Designs Merge 1960s Vibes with Modern Sustainability for a Timeless Trend

New York-based clothing brand, All Seeing Studios, is thrilled to announce its launch into the wholesale marketplace, innovating the fashion industry with unique, wearable artwork that combines fashion, spirituality and comfort. Each garment is intentionally designed to connect the wearer to the unseen energy and potential that surrounds us each day. Lovingly hand dyed and hand screened with Sara’s original liminal designs, all garments are created using water-based inks, and organic cotton or recycled materials, ensuring uncompromising style and comfort, but keeping with All Seeing Studios’ values of sustainability, craftsmanship, and ethical production, reinforcing the brand’s dedication to assuring a positive impact on our planet.

All Seeing Studios was ﬁrst launched in 2021 on the Northeast Arts & Crafts Fair circuit. Consumers were immediately drawn to Sara’s sense of spiritual design and wonder and soon a loyal following was born. In May 2024, Sara opened her ﬁrst retail location in the resort town of Ocean Beach, Fire Island, NY to immediate success. Now All Seeing Studios will bring their designs to a larger audience at MAGIC NYC 2024, offering the line to like-minded retailers across the country. On exhibit will be a selection of hand screened and hand dyed sweatshirts, tee shirts, hats, shorts and vintage denim — all featuring Sara’s unique designs. In addition, they will offer a made-to-order option, allowing a retailer to customize the designs for their speciﬁc geographic location.

“I have always been a spiritual person with an unexplained connection to the other side. I have channeled these beliefs into my artwork, creating themes surrounding energy, healing and most importantly: magic. I am inspired by the unseen energy and potential that surrounds us every moment of the day,” says Sara Rubenstein, artist and founder of All Seeing Studios. “My art focuses on that which is liminal, each piece lovingly created to bring the wearer to a state of openness and ﬂow.”

All Seeing Studios will be showcasing their unique brand of apparel at MAGIC NYC 2024 – Jacob Javits Center, September 22 – 24, 2024.

About Sara Rubenstein:

Sara has been an artist her entire life, following her dream of becoming a fashion designer. Graduating from high school at the age of 16, she set off for NYC to attend the Fashion Institute of Technology. There she developed her talent and creativity, but also became aware of the damage to the environment caused by the fashion industry.

Sara decided to break the cycle by creating a line of high quality, fashion forward, wearable artwork that is 100% eco-friendly and represents her spiritual connections to the unseen energies that surround us.

About ALL SEEING STUDIOS:

All Seeing Studios is a New York based fashion brand that combines spirituality with high-quality, eco-friendly design. It is a collection of wearable art committed to sustainable materials and ethical production methods.

For more information:

https://www.allseeingstudios.com

Instagram: @allseeingstudios

Media Contact
Company Name: All Seeing Studios
Contact Person: Sara Rubenstein
Email: Send Email
Country: United States
Website: https://www.allseeingstudios.com

Microdisplay Market worth $3.0 Billion in 2029, at a CAGR of 18.2%

“Microdisplay Market”

The global Microdisplay Market in terms of revenue is estimated to be worth $1.3 billion in 2024 and is poised to reach $3.0 billion by 2029, growing at a CAGR of 18.2% during the forecast period.

The report “Microdisplay Market by Product (NTE Devices, HUDs, Projectors), Technology (OLED, LCoS, MicroLED), Vertical (Consumer, Industrial and Enterprise, Automotive, Retail & Hospitality, Medical), Resolution and Brightness & Region – Global Forecast to 2029” The microdisplay industry is expected to reach USD 3.0 billion in 2029 from USD 1.3 billion in 2024, expanding at a CAGR of 18.2% during the forecast period.

The increase in demand for microdisplays is due to the integration of displays into various devices such as wearables and near-to-eye devices. The market may grow due to factors such as technological improvements in microdisplays such as MicroLED and OLEDoS technology, miniaturization trend in consumer electronics, increased usage of HMDs across a number of sectors, and growing global adoption of ADAS and HUDs in automotive sector.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=430

Browse 177 market data Tables and 59 Figures spread throug 244 Pages and in-depth TOC on “Microdisplay Market”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/micro-displays-market-430.html

NTE segment likely to lead the product segment during the forecast period.

The-NTE-devices-is projected to hold major market share of the microdisplay industry in 2029. NTE-devices include cameras, EVFs, and Head-Mounted Displays (HMDs). These devices are small, portable, and lightweight. They are equipped with microdisplays that point to the elements to be identified or viewed. Microdisplays are becoming more popular for use in applications involving cameras and electronic viewfinders (EVFs) than head-mounted displays. AR Head-Mounted Displays (HMDs) have been employed in pre-hospital care, clinical nursing, and inpatient medical therapy. While AR HMDs use microdisplays to reduce device size and enhance battery efficiency, VR HMDs provide users with computer-generated experiences within simulated environment. VR headsets are employed in various areas, including healthcare, retail, gaming and entertainment, and e-commerce.

Higher than FHD and 500 to 1000 nits’ segment are expected to expand at the highest CAGR in the resolution & brightness segment.

The higher than FHD segment of the microdisplay industry is forecast to have the most rapid growth in terms of CAGRs by 2029. Head-mounted displays often use microdisplays in this segment due to their immersive experiences and enhanced image quality. Higher FHD microdisplays have resolutions greater than 1920×1080. Also, in the brightness segment, the 500 to 1000 units on microdisplay market is likely to expand at highest CAGR during 2024 to 2029 periods. This growth trend has been attributed to increasing use of microdisplays in head-mounted devices and heads-up displays within a brightness range of 500-1000 nits.

Asia Pacific is estimated to account for the largest market share in the global microdisplay industry by 2029.

Asia Pacific is projected to lead the microdispaly industry from 2024 to 2029. In addition to the fact that Japan is home to several prominent EVF vendors, Asia-Pacific is expected to continue to have the highest demand for microdisplays to be used in NTE devices during the projected timeframe. Major camera manufacturers are based in Asia Pacific region. For instance, Canon, Nikon, and Sony together comprises of more than 90% of the camera market. As a result, Japan’s demand for microdisplays fuels expansion in the microdisplay industry throughout the region. Furthermore, Asia Pacific is predicted to be the largest LCD microdisplay industry from 2024 to 2029. LCD microdisplays are in high demand in cameras, EVFs, and projectors, with the majority of vendors located in this region. The market in this region is predicted to grow rapidly, driven mostly by growing economies and an increasing number of small- and medium-sized enterprises, as well as government-imposed digital transformation regulations.

Microdisplay Industry Key Players

Seiko Epson Corporation (Japan), SeeYA Technology (China), Sony Group Corporation (Japan), Kopin Corporation (US), Himax Technologies, Inc. (Taiwan), and HOLOEYE Photonics AG (Germany) are some of the major companies in the microdisplay industry.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Microdisplay Market worth $3.0 Billion in 2029, at a CAGR of 18.2%

myFirst Unveils the myFirst Camera 50: A Perfect Blend of Fun and Learning for Young Photographers

myFirst, a leader in innovative tech for children, from their kids smart watch to kids 3D printing tools, is excited to announce the launch of the myFirst Camera 50, a new entry-level camera designed specifically for budding photographers aged 5 and up. Combining user-friendly features with high-quality performance, the myFirst Camera 50 empowers children to explore their creativity while developing essential skills in photography.

The myFirst Camera 50 is engineered with vibrant colors and a lightweight design, making it perfect for small hands. Featuring a durable, kid-proof casing, the camera is built to withstand the inevitable bumps and drops that come with active play. Parents can feel confident that their investment is protected while encouraging their children to learn and grow.

Key Features of the myFirst Camera 50:

5-Megapixel Camera: Capture high-resolution photos and 720p videos, allowing kids to document their adventures in stunning detail.
User-Friendly Interface: Designed with young users in mind, the intuitive interface makes it easy for kids to navigate through modes and settings.
Fun Filters and Frames: Kids can enhance their creativity with a variety of built-in filters and frames, turning every shot into a unique masterpiece.
Rechargeable Battery: The myFirst Camera 50 comes with a rechargeable battery that ensures hours of fun without the hassle of disposable batteries.
Educational Resources: Each camera includes access to online tutorials and tips that help kids learn about photography techniques, composition, and storytelling through images.

G-Jay Yong, Co-founder and CEO of myFirst, said, “Parents in the US have been asking us when they could get onto our kids tech ecosystem as they’re very concerned about their kids’ safety online and also in the real world, so now we can assure them we are ready.”

In addition to being a fantastic tool for creativity, the myFirst Camera 50 also encourages outdoor exploration and family bonding. Children can take their camera on hikes, family outings, or simple backyard adventures, creating cherished memories while developing their photography skills.

The myFirst Camera 50 is available for pre-order starting today and will be officially launched Sept 18, 2024. Customers can purchase the camera through the myFirst website and select retail partners nationwide.

About myFirst Tech Holdings Pte Ltd.

The inception of myFirst in 2017 was fueled by a team of dedicated fathers, aware of the growing need to safely integrate technology into their children’s playtime. They recognized a gap in the market for kid-friendly tech products that weren’t just toys but gateways to learning and creativity. This led to the creation of the myFirst Camera, now a leading kids’ camera brand in Korea, but the brand is well known for other technology centered around kids’ creativity and safety.

Media Contact
Company Name: myFirst Tech Holdings
Contact Person: Luis Nunez
Email: Send Email
Phone: (619) 848-0692
Address:17411 Gale Ave
City: City of Industry
State: California 91748
Country: United States
Website: https://us.myfirst.tech/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: myFirst Unveils the myFirst Camera 50: A Perfect Blend of Fun and Learning for Young Photographers